TP53 and cancer: Furthermore, previous studies demonstrate that exogenous sources of IL-6 reduce p53 stabilization and protein expression, either via STAT3-dependent or -independent mechanism, leading to increased cancer cell survival under genotoxic conditions [10, 58].